CRISPR/Cas9 gene-editing platform corrects mutations associated with Duchenne muscular dystrophy

被引：0
|
作者：
Heather Wood
机构：
来源：
Nature Reviews Neurology | 2015年 / 11卷 / 4期
关键词：
D O I：
10.1038/nrneurol.2015.37
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：184 / 184
相关论文
共 50 条
  • [1] Duchenne muscular dystrophy: CRISPR/Cas9 treatment
    Jerry R Mendell
    Louise R Rodino-Klapac
    Cell Research, 2016, 26 : 513 - 514
  • [2] Duchenne muscular dystrophy: CRISPR/Cas9 treatment
    Mendell, Jerry R.
    Rodino-Klapac, Louise R.
    CELL RESEARCH, 2016, 26 (05) : 513 - 514
  • [3] CRISPR/Cas9 mediated gene editing of Duchenne muscular dystrophy with a single gene deleted adenoviral vector
    Ehrke-Schulz, E.
    Mouly, V.
    Ehrhardt, A.
    HUMAN GENE THERAPY, 2019, 30 (11) : A161 - A161
  • [4] CRISPR/Cas9-Mediated Gene-Editing Rescues Dystrophin Expression in a Dog Model of Duchenne Muscular Dystrophy
    Maruyama, Rika
    Quynh Nguyen
    Aoki, Yoshitsugu
    Takeda, Shin'ichi
    Yokota, Toshifumi
    MOLECULAR THERAPY, 2018, 26 (05) : 121 - 121
  • [5] Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy
    Lim, Kenji Rowel Q.
    Yoon, Chantal
    Yokota, Toshifumi
    JOURNAL OF PERSONALIZED MEDICINE, 2018, 8 (04):
  • [6] Further development of a CRISPR/Cas9 platform for 60% of Duchenne muscular dystrophy patients
    Fernandez, Karla
    FASEB JOURNAL, 2017, 31
  • [7] CRISPR/Cas9 gene-editing strategies in cardiovascular cells
    Vermersch, Eva
    Jouve, Charlene
    Hulot, Jean-Sebastien
    CARDIOVASCULAR RESEARCH, 2020, 116 (05) : 894 - 907
  • [8] Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening 
    Patricia Soblechero-Martín
    Edurne Albiasu-Arteta
    Aina Anton-Martinez
    Laura de la Puente-Ovejero
    Iker Garcia-Jimenez
    Gabriela González-Iglesias
    Irene Larrañaga-Aiestaran
    Andrea López-Martínez
    Javier Poyatos-García
    Estíbaliz Ruiz-Del-Yerro
    Federico Gonzalez
    Virginia Arechavala-Gomeza
    Scientific Reports, 11
  • [9] Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening
    Soblechero-Martin, Patricia
    Albiasu-Arteta, Edurne
    Anton-Martinez, Aina
    de la Puente-ovejero, Laura
    Garcia-Jimenez, Iker
    Gonzalez-Iglesias, Gabriela
    Larranaga-Aiestaran, Irene
    Lopez-Martinez, Andrea
    Poyatos-Garcia, Javier
    Ruiz-Del-Yerro, Estibaliz
    Gonzalez, Federico
    Arechavala-Gomeza, Virginia
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [10] Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach
    Tremblay, Jacques P.
    Lyombe-Engembe, Jean-Paul
    Duchene, Benjamin
    Ouellet, Dominique L.
    MOLECULAR THERAPY, 2016, 24 (11) : 1888 - 1889
12345